Skip to main content
Sopharma AD logo

Sopharma AD — Investor Relations & Filings

Ticker · SFA ISIN · BG11SOSOBT18 LEI · 097900BGGW0000048796 BSOBGN Manufacturing
Open in API
Filings indexed 1,479 across all filing types
Latest filing 2026-01-28 Director's Dealing
Country BG Bulgaria
Listing BSOBGN SFA

About Sopharma AD

https://www.sopharmagroup.com/

Sopharma AD is a pharmaceutical company founded in 1933 that specializes in the production, distribution, and export of a wide range of medical products. The company's portfolio includes prescription (Rx) and over-the-counter (OTC) medicines, encompassing both branded and generic drugs. A key area of focus is its traditional plant-based products. Sopharma develops treatments for various conditions, including liver disease, pain management, and smoking cessation. Operating from EU-GMP certified facilities, the company also provides contract manufacturing services and has an established presence in over 40 international markets.

Recent filings

Filing Released Lang Actions
Notification from Vesela Stoeva under Regulation 596/2014 for exercise of rights for issue of warrants with ISIN ą BG4000002262
Director's Dealing Classification · 100% confidence The document follows the standard template for a notification of a transaction by a person discharging managerial responsibilities (PDMR) as required by Article 19 of the EU Market Abuse Regulation (MAR) 596/2014. It identifies the individual (Vesela Stoeva), their position (Deputy Chairman of the Board), the issuer (Sopharma AD), and the specific details of the transaction (exercise of rights). This is a classic Director's Dealing notification.
2026-01-28 English
Notification from Vesela Stoeva under Regulation 596/2014 for exercise of rights for issue of warrants with ISIN ą BG4000001264
Director's Dealing Classification · 100% confidence The document is a standard notification form for transactions conducted by persons discharging managerial responsibilities (PDMRs), specifically citing Regulation (EU) No 596/2014 (MAR). It details a transaction by Vesela Stoeva, a Deputy Chairman of the Board of Directors of 'Sopharma' AD, involving the exercise of rights. This falls directly under the definition of 'Director's Dealing' (DIRS).
2026-01-28 English
Notification from "Donev Investments holding" AD under Regulation 596/2014 for exercise of rights for issue of warrants with ISIN ą BG4000003260
Director's Dealing Classification · 100% confidence The document is a standard template for the notification of transactions by persons discharging managerial responsibilities (PDMRs) as required by Article 19 of the EU Market Abuse Regulation (MAR) 596/2014. It explicitly identifies the person discharging managerial responsibilities (Ognian Donev) and the legal entity (Donev Investments Holding AD) conducting the transaction in the issuer's (Sopharma AD) financial instruments. This falls under the category of Director's Dealing.
2026-01-28 English
Notification from "Donev Investments holding" AD under Regulation 596/2014 for exercise of rights for issue of warrants with ISIN ą BG4000002262
Director's Dealing Classification · 100% confidence The document follows the standard template for 'Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them' as required by Article 19 of the EU Market Abuse Regulation (MAR). It identifies a person discharging managerial responsibilities (PDMR), specifically 'Donev Investments Holding' AD, and details a transaction involving financial instruments (rights) related to the issuer 'Sopharma' AD. This is a classic Director's Dealing disclosure.
2026-01-28 English
Notification from "Donev Investments holding" AD under Regulation 596/2014 for exercise of rights for issue of warrants with ISIN ą BG4000001264
Director's Dealing Classification · 100% confidence The document is a standard notification form for transactions by persons discharging managerial responsibilities (PDMRs) as required by Regulation (EU) No 596/2014 (MAR). It explicitly identifies Ognian Donev, an executive director, and details his transaction involving financial instruments of 'Sopharma' AD. This falls directly under the category of Director's Dealing.
2026-01-28 English
Notification for sale of treasury shares
Transaction in Own Shares Classification · 100% confidence The document is a formal notification regarding the sale of treasury shares by 'Sopharma' AD. It specifies the number of shares sold, the percentage of share capital, the total value, and the average price per share, while also updating the total number of treasury shares held by the company. This aligns perfectly with the definition of 'Transaction in Own Shares' (POS).
2026-01-28 English

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.